These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9119131)

  • 1. Retrovirus screening of vaccine cell substrates.
    Khan AS
    Dev Biol Stand; 1996; 88():157-62. PubMed ID: 9119131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
    Petricciani JC; Milstien JB
    Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates.
    Khan AS; Sears JF
    Dev Biol (Basel); 2001; 106():387-92; discussion 392-3. PubMed ID: 11761254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction/activation and detection of occult viral agents present in mammalian cells.
    Schüpbach J
    Dev Biol (Basel); 2001; 106():425-37; discussion 465-75. PubMed ID: 11761258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of manufacturers and developers of cell culture-derived products for evidence of adventitious contamination.
    Lubiniecki AS
    Dev Biol Stand; 1996; 88():195-7. PubMed ID: 9119136
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular methods for virus discovery.
    Jarrett RF; Johnson D; Wilson KS; Gallagher A
    Dev Biol (Basel); 2006; 123():77-88; discussion 119-32. PubMed ID: 16566437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF
    Dev Biol (Basel); 2001; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines.
    André M; Morgeaux S; Fuchs F
    Biologicals; 2000 Jun; 28(2):67-80. PubMed ID: 10885614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the issues: detection of retroviruses and associated risks.
    Marcus-Sekura CJ
    Dev Biol Stand; 1992; 76():137-40. PubMed ID: 1478334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for adventitious agent assays.
    Robertson JS
    Dev Biol Stand; 1996; 88():37-40. PubMed ID: 9119160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of retroviral detection for rodent cell-derived products and gene therapy applications.
    Hughes JV; Messner K; Burnham M; Patel D; White EM
    Dev Biol Stand; 1996; 88():297-304. PubMed ID: 9119153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of cytochemistry and electron microscopy to the detection of contaminants in the cell material used for the production of virus vaccines.
    Rau C; Palade V; Voiculescu C; Samoilescu M
    Dev Biol Stand; 1976 Dec 13-15; 37():245-8. PubMed ID: 201521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues of biological assays for viral vaccines.
    Lee CK
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian cells and their contaminants.
    Minor PD
    Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
    [No Abstract]   [Full Text] [Related]  

  • 15. Retroviral aspects of the characterisation of avian and mammalian cell substrates.
    Robertson JS
    Dev Biol (Basel); 2001; 106():417-22; discussion 422-4, 465-75. PubMed ID: 11761257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay.
    Chang A; Dusing S
    Dev Biol (Basel); 2006; 123():91-7; discussion 119-32. PubMed ID: 16566438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents.
    Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389
    [No Abstract]   [Full Text] [Related]  

  • 18. Current issues in viral assays and viral clearance evaluation.
    Lubiniecki AS
    Dev Biol Stand; 1996; 88():9-11. PubMed ID: 9119167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.
    Audet SA; Crim RL; Beeler J
    Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of replication competent retrovirus and lentivirus.
    Sastry L; Cornetta K
    Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.